Wave Life Sciences WVE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $38.25M+317% | —— | —— | $8.7M-55.8% | $9.18M-26.8% | ||
| $47.44M+16.8% | $52.81M+18.3% | $45.87M+11.4% | $43.47M+7.6% | $40.62M+21.5% | ||
| $22.1M+20.4% | $20.9M+29.5% | $18.09M+20.2% | $17.99M+25.8% | $18.36M+35.5% | ||
| $69.54M+17.9% | $73.71M+21.3% | $63.96M+13.7% | $61.46M+12.4% | $58.98M+25.5% | ||
| $69.54M+17.9% | $73.71M+21.3% | $63.96M+13.7% | $61.46M+12.4% | $58.98M+25.5% | ||
| -$31.3M+37.2% | -$56.47M— | -$56.35M+11.8% | -$52.76M-50.8% | -$49.8M-44.5% | ||
| -81.8%+461pp | —— | —— | -606.5%-429pp | -542.8%-268pp | ||
| $5.29M+84.0% | $3.05M-18.3% | $2.18M+21.1% | $2.37M+13.4% | $2.88M+13.4% | ||
| $5.21M+78.1% | $3.29M-47.7% | $2.5M+17.1% | $2.29M+10.4% | $2.93M+0.9% | ||
| -$26.09M+44.4% | -$53.18M— | -$53.85M+12.8% | -$50.47M-53.3% | -$46.88M-48.5% | ||
| $0— | -$0— | $0— | $0— | $0— | ||
| -$26.09M+44.4% | -$53.18M— | -$53.85M+12.8% | -$50.47M-53.3% | -$46.88M-48.5% | ||
| -68.2%+443pp | —— | —— | -580.2%-413pp | -510.9%-259pp | ||
| -$0.13+55.2% | -$0.29— | -$0.32+31.9% | -$0.31-24.0% | -$0.29-20.8% | ||
| -$0.13+55.2% | -$0.29— | -$0.32+31.9% | -$0.31-24.0% | -$0.29-20.8% | ||
| 200.2M+23.1% | 168.6M+22.0% | 167.7M+26.5% | 164M+26.6% | 162.6M+25.8% | ||
| 200.2M+23.1% | 168.6M+22.0% | 167.7M+26.5% | 164M+26.6% | 162.6M+25.8% | ||
| -$26.09M+44.3% | -$53.24M— | -$53.88M+12.6% | -$50.43M-52.8% | -$46.82M-48.0% | ||
| -$4K-107% | —— | -$29K-124% | $43K+153% | $58K+178% | ||
| -$80K-257% | $234K-90.8% | $324K-3.9% | -$82K-356% | $51K-86.0% | ||
| $38.25M+317% | —— | —— | $8.7M-55.8% | $9.18M-26.8% | ||
| -$31.3M+37.2% | -$56.47M— | -$56.35M+11.8% | -$52.76M-50.8% | -$49.8M-44.5% | ||
| -$30.46M+37.8% | -$55.62M— | -$55.5M+11.9% | -$51.89M-52.6% | -$48.93M-46.4% | ||
| -$30.46M+37.8% | -$55.62M— | -$55.5M+11.9% | -$51.89M-52.6% | -$48.93M-46.4% | ||
| -79.6%+454pp | —— | —— | -596.6%-424pp | -533.3%-267pp | ||
| -$31.3M+37.2% | -$56.47M— | -$56.35M+11.8% | -$52.76M-50.8% | -$49.8M-44.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Wave Life Sciences's revenue?
- Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.
- Is Wave Life Sciences profitable?
- Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.
- What is Wave Life Sciences's earnings per share?
- Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.
- Where does Wave Life Sciences's income statement data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
